Latham Wins Financial Times Asia-Pacific Innovative Lawyers Award for Healthcare
Firm recognized for advising Beijing-headquartered Sinovac on funding for COVID-19 vaccine development.
Benjamin Su represents Asia-based clients on cross-border corporate and US securities law matters, particularly involving companies in the technology sector.
Benjamin leverages more than two decades’ experience navigating global markets and extensive knowledge of US securities law to guide companies and investment banks on:
He has worked extensively across the Greater China region, particularly in the technology sector, including semiconductors, electric vehicles, renewable energy, artificial intelligence, fintech, and ecommerce. Benjamin understands Chinese issuers’ and international underwriters’ commercial objectives in capital markets transactions and crafts responsive, pragmatic solutions.
Benjamin’s experience includes advising:
Firm recognized for advising Beijing-headquartered Sinovac on funding for COVID-19 vaccine development.